Skip to main content

Table 2 Overview of CK19+ results in volunteers, benign tumor patients and stage I–IV breast cancer patients

From: Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection

 

Total number

Positive Detection Rate

Healthy control

25

0/25 (0%)

Benign tumor

7

0/7 (0%)

Stage I patients

4

0/4 (0%)

Stage II patients

23

2/23 (9%)

Stage III patients

7

5/7 (70%)

Stage IV patients

7

6/7 (86%)

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us